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ABSTRACT
Canine mammary carcinoma (CMC) has been used as a model to investigate the pathogenesis of human breast cancer and
the same grading scheme is commonly used to assess tumor malignancy in both. One key component of this grading scheme
is the density of mitotic figures (MF). Current publicly available datasets on human breast cancer only provide annotations for
small subsets of whole slide images (WSIs).
We present a novel dataset of 21 WSIs of CMC completely annotated for MF. For this, a pathologist screened all WSIs for
potential MF and structures with a similar appearance. A second expert blindly assigned labels, and for non-matching labels, a
third expert assigned the final labels. Additionally, we used machine learning to identify previously undetected MF. Finally, we
performed representation learning and two-dimensional projection to further increase the consistency of the annotations.
Our dataset consists of 13,907 MF and 36,379 hard negatives. We achieved a mean F1-score of 0.791 on the test set and of
up to 0.696 on a human breast cancer dataset.
Background & Summary
Histologic assessment of tissue is the gold standard in tumor diagnosis and prognostication and is a key component in the
selection of the best suited therapy. For the diagnosis of mammary carcinoma, pathologists grade the tumor according to the
scheme by Elston and Ellis1. The scheme is based on three criteria: nuclear pleomorphism, tubule formation, and mitotic count.
Out of these, a component that is known to have high inter- and intra-rater discordance is the mitotic count, i.e. the relative
density of cells undergoing cell division per standardized area2–5.
While disagreement between experts for individual mitotic figures may be one cause of this, the region of the microscope
slide upon which the mitotic count is performed may also have a strong influence, due to patchy distribution of mitotic figures
(tumor heterogeneity). Common to most grading schemes, the mitotic count is recommended to be performed in ten consecutive
fields representing the field of view area of an optical microscope at 400x magnification (so-called high power field or HPF).
The location within the tumor is specified less precisely, but many grading schemes suggest an area at the periphery of the
tumor, where the tumor cells are assumed to have greater capacity for proliferation (invasion front). This underlying assumption,
however, has not yet been shown to be generally true in mammary carcinoma to the best of the authors’ knowledge. In fact,
areas with the highest proliferation density ("hot spots") have been shown to have greater prognostic information than the
periphery (invasive edges) based on another quantitative parameter of tumor cell proliferation (Ki67)6.
Variable density of mitotic figures within tumors results in less than optimal reproducibility of the MC, which causes
a dilemma for its use in prognostication. While we can expect that counting of mitotic figures is of high value due to its
representation of tumor biological behavior and growth, due to the aforementioned problems, sub-optimal mitotic counts may
lead to inaccurate grading, which can impede prognostication and lead to unexpected or unpredictable outcomes. An optimal
mitotic count would thus require a substantially reduced subjective component with precise categorization of individual mitotic
figure candidates. Additionally, the optimal mitotic count would be available for the complete whole slide image (WSI) - or,
better: for several WSIs, ideally representing the complete tumor. Neither of these processes can be performed manually by a
pathologist within the scope of clinical practice, thus algorithmic support for pathologists by means of a decision support system
would be beneficial. This creates a very favorable case for algorithmic support of the pathologist by means of a decision support
system. Additionally, since the advent of deep learning-based pattern recognition pipelines, we have seen vast improvements in
accuracy of detection systems, given that a sufficient amount of high quality labeled data is available for the task.
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Figure 1. Examples of mitotic figures and structures with a similar appearance. Due to ambiguities, precise classification for
some candidates is not straightforward.
Motivated by this, a number of challenges have been held for the task of mitotic figure detection in recent years7–10. Leaving
aside the results on the MITOS 2012 dataset7 (which should no longer be considered state-of-the-art due to selection of the
training and test datasets from the same images) the results achieved in these challenges yielded F1 scores of below 0.6610,
which can still be regarded as insufficient for clinical use. Multiple factors can be expected to play a role in this: First, we can
assume a less than optimal label quality. Detection of mitotic figures occurs intermittently, thus the probability of missing a
portion of mitotic figures on large images is high. Second, as shown by other authors2, 4, 11, agreement on individual, identified
mitotic figure candidates, is also far less than perfect (likely depending on the phase in the cell division cycle). Looking only at
the final results it is thus hard to judge whether the algorithmic solution is non-optimal or the label noise on the test set is just
too high. A third root cause for the results not matching clinical expectations is the low quantity of images and annotations,
given the high variability of tissues. Besides the process of mitosis itself, there are numerous other causes for high variability in
hematoxylin and eosin (H&E)-stained microscopy images, including thickness of specimen, concentration and protocol of
dying, and optical and calibration properties of the microscope or whole slide scanner that was used.
The answer to all of these challenges can, from our point of view, only be a significant increase in data quantity and
quality. All previous datasets of mammary carcinomas only provide annotations for a rather small part of each WSI selected
by one expert pathologist9. If algorithmic pipelines should be able to process complete WSIs, this does, however, assume
generalization of these areas to the complete slide. Motivated by the findings in our previous work12, we need to challenge this
assumption. In necrotic or unpreserved regions of the specimen, there may be numerous cells or structures which represent
artifacts, but have morphologic overlap with mitotic figures (mitotic-like figures or hard negatives). In order to perform and
assess the detection on whole slide images, we thus depend on the availability of annotation data for complete slides. The image
quality on the slide is not equally perfect in all regions, which poses an additional burden on the annotation. It is, however, of
utmost importance to not only include easily identifiable positive and negative examples, but also to include hard examples.
Mammary carcinoma is not only prevalent in women, but is also a frequently diagnosed tumor for female dogs (bitches).
Due to similarities in epidemiology, biology, and clinical pathology, dogs have been proposed as a model animal to study
invasive mammary carcinoma13, 14. Besides the application of increased accuracy and cost effectiveness in the treatment of
canine tumors, human mammary carcinoma assessment can also benefit from these canine histopathology datasets which
provide annotations for entire WSIs, unlike previous datasets of human breast cancer.
In this work, we present a novel, large-scale dataset of canine mammary carcinoma, providing annotations for 21 complete
whole slide images of H&E-stained tissue. We evaluated the quality of the dataset by using state-of-the-art pattern recognition
pipelines based on two stages of deep convolutional neural networks. Additionally, we tested the pipelines trained with our
dataset on the largest available human mammary carcinoma dataset (TUPAC1610).
Methods
Selection and preparation of specimen
All specimens were taken retrospectively from the histopathology archive of an author (R.K.) with approval by the local
governmental authorities (State Office of Health and Social Affairs of Berlin, approval ID: StN 011/20). Specimens of breast
tissue from bitches had been surgically removed by the treating veterinarian for purely diagnostic purposes for cases suspicious
of mammary neoplasia. The tissue had been routinely fixed in formalin and embedded in paraffin. For this study new tissue
sections were produced from the tissue blocks and staining with hematoxylin and eosin using an automated slide stainer
(ST5010 Autostainer XL, Leica, Germany). Case selection was random and specimens with acceptable tissue quality were
included. All images were digitized using a linear whole slide scanner (Aperio ScanScope CS2, Leica, Germany) at a resolution
of 0.25 microns per pixel (400X).
Manually Expert Labeled (MEL) Dataset
Labeling mitotic figures accurately requires a great deal of expertise in the field of tumor pathology. Additionally, it is a
labor-intensive task that requires a high level of concentration throughout the process. To set a baseline, an expert pathologist
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Figure 2. Generation of the object detection-augmented and expert-labeled dataset (ODAEL). Adapted from Bertram et al.12.
with some years of experience in mitotic figure detection (C.A.B.) screened each WSI twice for mitotic figures. For this, a
specialized software solution15 was used that provides a screening mode. This mode presents overlapping image patches
selected from the WSI in regions where tissue is present. Whenever the expert was done with a given image section, the
program would propose the next suitable image patch. This ensures that no portion of the image was left out in this assessment.
Besides mitotic figures, the expert annotated similar appearing objects that could be confused with mitotic figures based on
their visual appearance, but, do not represent cells in the state of cell division. This was the precondition for the next step: It is
widely known, that inter-rater discordance can be high for mitotic figures2–5. To reduce the subjective effect of this rater, we
asked a second expert (R.K.), who is a senior pathology expert with several years of experience in mitotic figure assessment.
The expert was given the task to assess for each of the annotated objects (the labels were blinded for him) a new label (mitotic
figure or mitotic figure look-alike). This results in two independent expert opinions for every single object of interest. For
disagreed labels (N = 1,268 / 39,868), agreement was initially obtained by consensus of the first and second pathologist. This
preliminary dataset was used for augmented dataset development using machine learning and data analysis techniques (see
below). Final agreement for ground truth, which was used for technical validation of the dataset, was obtained through majority
vote by a third pathologist (T.A.D.). Agreement through majority vote was commonly performed in human mitotic figure breast
cancer datasets8, 10.
Object-Detection Augmented and Expert Labeled (ODAEL) Dataset
While one expert screened the WSIs with the help of a dedicated software solution and with great diligence, we still have to
assume that, due to the partially infrequent occurrence of mitotic figures, the expert might have missed a certain percentage of
mitotic figures. To take this into account, we employed a machine learning-based pipeline to find candidates for missed mitotic
figures to be presented to the experts (see Figure 2). For this, we first split a preliminary dataset into three parts (each 7 WSIs),
which were then subsequently each used once as a test set for a CNN-based object detector, with the WSIs of the other two
parts used as training set. We used a customized version12 of RetinaNet16 for this purpose. All objects detected by the network
were subsequently checked for existence in the MEL dataset variant. Second, we trained a cell classifier on 128 px patches
cropped around the cells annotated in the currently used training part of the MEL dataset and ran the inference with all newly
identified mitotic figure candidates. The cell patches were grouped into 10 groups according to their model score (where 1.0
represented cells being very likely a mitotic figure, and 0.0 very unlikely, respectively). All mitotic figures were initially shown
to the first pathologist and the second pathologist independently, and in case of disagreement, the third expert rendered the
final vote, like in the previous dataset variant. Through this procedure, the number of mitotic figures was increased by 6.06%
compared to the MEL dataset (see Table1), which is in line with previous findings12. The number of non-mitotic cells was
increased much more significantly (+36.22%). The reason for this is that all candidates that were identified by the RetinaNet
(even those with low scores) were added to the list of non-mitotic figures. Comparing the individual tumor cases, we can see
that the relative increase in mitotic figures is higher for the tumors with less overall mitotic figures. This highlights that missing
mitotic figures is more likely for lower grade tumors due to the rareness of the event.
Clustering and Object-Detection Augmented and Expert Labeled (CODAEL) Dataset
While the previous, machine-learning driven approach was aimed at identifying previously missed mitotic figures, we still
have to take into account that the dataset suffers from a certain degree of inconsistency due to misclassification. While it is
commonly easy to identify a clear mitotic figure and a clearly non-mitotic cell, there are a significant amount of cells where this
differentiation is not easy to make (see Figure 1). In this assessment, the experts have to create a visual and perceptual cutoff
that pertains to judging what represents a mitotic figure. This cutoff may, however, not be constant over time. Both sources of
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Figure 3. Generation of the Clustering and Object Detection-Augmented Expert Labeled (CODAEL) dataset variant by
reassessment of mitotic figures (red) and hard negatives (blue) in a clustered visual representation.
inconsistency, i.e., the varying cutoffs over time as well as plain human error, can be counteracted by clustering with subsequent
reevaluation.
For this, we cropped out patches of all cells (mitotic figures and hard negatives) in the database and trained a ResNet1817-
based classifier for 10 epochs using standard binary cross-entropy. In order to enable a better clustering, we used methods
from representation learning in the next step: we removed the last layer of the network and trained the network for another
10 epochs using contrastive loss18. The resulting feature vector of all images were subsequently transformed into a two
dimensional representation using uniform manifold approximation and projection (UMAP), resulting in two coordinates in the
2D representation for each image (see 3).
Next, the image patches were inserted into a new image according to an upscaled version of these coordinates, as described
by Marzahl et al19: To avoid interference of image patches, a grid with tile size according to the patch size was constructed.
The patch was then pasted into the grid according to a least distance between grid coordinates and coordinates as given by the
projection. Whenever a position in the grid was already filled, the tile was placed on the next possible grid position with least
distance. This resulted in an 80,000×60,000 px image, containing all 50,286 individual cell patches (see center of Figure 3).
In this image, all patches representing a mitotic figure were given a red box as a rectangle, and all patches representing a
non-mitotic cell a blue rectangle. Next, the first pathology expert re-assessed all mitotic figures in this graphical representation.
While potentially also introducing a bias, the representation facilitated identification of labeling errors as well as comparisons
to similar appearing objects, thus increasing consistency. Expert driven classification changes occurred for 621 non-mitotic
figures (changed to mitotic figures) and 771 mitotic figures (to non-mitotic figures) with a total of 1392 classification changes.
To reduce the bias introduced by the pipeline and its graphical representation, we presented all changes from the first expert
to the second expert, however, 2D mapping was omitted and only patches of 128 px size were assessed. The second expert
disagreed only in a minority of cases. In total, decisions were overruled in 109 cases (7.8%), resulting in 42 cells classified as
mitotic figures and 67 cells classified as non-mitotic cells/structures. The disagreements were lastly given to a third expert for a
majority ruling, as shown in Figure 3. The final CODAEL datset with majority vote by a third pathologists contains 13,907
mitotic figures, as shown in Table 1.
Code availability
All code used in the experiments described in the manuscript was written in Python 3 and is available through our GitHub
repository (https://github.com/DeepPathology/MITOS_WSI_CMC/). We provide all necessary libraries as well
as Jupyter Notebooks allowing tracing of our results. The code is based on fast.ai20 and OpenSlide21 and provides some custom
data loaders for use of the dataset.
Data Records
The dataset, consisting of 21 anonymized WSIs in Aperio SVS file format, is publicly available on figshare. Alongside, we
provide cell annotations according to both classes in a SQLite3 database. For each annotation, this database provides:
• The WSI of the annotation
• The absolute center coordinates (x,y) on the WSI
• The class labels, assigned by all experts and the final agreed class. Each annotation label is included in this, resulting in
at least two labels (in the case of initial agreement and no further modifications), one by each expert. The unique numeric
identifier of each label furthermore represents the order in which the labels were added to the database.
Case No. File name tumor area No. of mitotic figures No. of non-mitotic cells set
(MEL/ODAEL/CODAEL) (MEL/ODAEL/CODAEL)
1 4eee7b944ad5e46c60ce.svs 66.06 mm2 47 / 61 / 64 114 / 196 / 193 test
2 a8773be388e12df89edd.svs 37.01 mm2 64 / 71 / 74 204 / 591 / 588 train
3 deb768e5efb9d1dcbc13.svs 187.43 mm2 92 / 96 / 84 287 / 472 / 484 train
4 e09512d530d933e436d5.svs 214.97 mm2 87 / 98 / 102 602 / 742 / 738 test
5 72c93e042d0171a61012.svs 26.29 mm2 130 / 151 / 140 375 / 680 / 691 train
6 2d56d1902ca533a5b509.svs 49.32 mm2 139 / 155 / 153 228 / 365 / 367 test
7 084383c18b9060880e82.svs 41.71 mm2 157 / 173 / 160 404 / 547 / 560 train
8 da18e7b9846e9d38034c.svs 253.10 mm2 187 / 210 / 211 991 / 1,354 / 1,353 train
9 13528f1921d4f1f15511.svs 339.93 mm2 283 / 301 / 292 963 / 1,127 / 1,136 test
10 d0423ef9a648bb66a763.svs 273.88 mm2 378 / 411 / 354 1,143 / 1,596 / 1,653 train
11 69a02453620ade0edefd.svs 45.35 mm2 634 / 642 / 612 1,407 / 1,505 / 1,535 test
12 d37ab62158945f22deed.svs 226.39 mm2 578 / 651 / 674 1,105 / 1,725 / 1,702 train
13 d7a8af121d7d4f3fbf01.svs 426.92 mm2 716 / 746 / 720 1,832 / 2,373 / 2,399 train
14 460906c0b1fe17ea5354.svs 112.24 mm2 673 / 742 / 754 1,199 / 2,480 / 2,468 train
15 b1bdee8e5e3372174619.svs 231.84 mm2 812 / 861 / 869 1,260 / 1,832 / 1,824 test
16 c4b95da36e32993289cb.svs 257.01 mm2 1,097 / 1,114 / 1,085 2,454 / 2,944 / 2,973 train
17 022857018aa597374b6c.svs 325.81 mm2 1,290 / 1,344 / 1,320 2,463 / 3,106 / 3,130 test
18 50cf88e9a33df0c0c8f9.svs 269.25 mm2 1,197 / 1,339 / 1,337 1,632 / 2,550 / 2,552 train
19 3d3d04eca056556b0b26.svs 513.28 mm2 1,383 / 1,465 / 1,447 2,110 / 2,933 / 2,951 train
20 2191a7aa287ce1d5dbc0.svs 96.38 mm2 1,449 / 1,485 / 1,462 2,155 / 2,609 / 2,632 train
21 fa4959e484beec77543b.svs 365.91 mm2 1,949 / 2,035 / 1,993 3,598 / 4,408 / 4,450 train
total 4,360.07 mm2 13,342 / 14,151 / 13,907 26,526 / 36,135 / 36,379 total
Table 1. Overview of the individual slides of the final dataset. For each slide, the number of mitotic figures and number of
non-mitotic structures (hard negatives) is given for each of the three dataset variants: manually expert labeled (MEL), object
detection-augmented and expert labeled (ODAEL) and clustering and object detection-augmented and expert
labeled (CODAEL).
We also provide polygon annotations for the tumor area within the WSI. The polygon annotations consist of multiple
coordinates linked to a single annotation. The publicly available libraries provided by the SlideRunner15 python package can be
used to conveniently extract those. The WSIs and all annotations can also be viewed using this open source software.
Table 1 gives an overview about the database and all its variants, sorted by the number of mitotic figures in the CODAEL
dataset variant. The number of mitotic figure look-alike cells is almost three times higher than the number of mitotic figures,
and this factor is lower for the manually labeled dataset variants. The table also indicates which WSIs were assigned to the
training set and which to the test set.
We also investigated the count of mitotic figures. In most grading schemes1, 22 this is defined as ten consecutive high power
fields (10 HPF, representing an area of 2.37mm2 for the most commonly used microscope settings23). We chose an area of 10
HPF with an aspect ratio of 4:3 and used a moving window summation over all mitotic figure events to derive the mitotic count.
As most grading schemes recommend to perform the mitotic count where there is the highest mitotic activity, we took the
absolute maximum of this two-dimensional mitotic count map. The distribution of the mitotic figures per 10 HPF area within
the complete tumor area can be seen in Figure 4: As evident from the examples depicted, there is heterogenous distribution
of mitotic figures throughout the tumors. Thus, the mitotic count is highly dependent on the correct determination of the
area of maximum mitotic activity. Notably, in almost all cases the higher cutoff value of 101 is exceeded. Since finding the
optimal threshold is, however, so strongly dependent on the position, we can assume that these would have to be adjusted for an
automatic mitotic figure detection-based grading scheme. In total, the experts annotated a tumor area of 4,360.07mm2, greatly
exceeding the state-of-the-art in mammary carcinoma datasets, which is given by the TUPAC16 dataset (251.5mm2) and similar
to the canine cutaneous mast cell tumor dataset12.
Getting started
We provide a github-repository, including all experiments described in this manuscript. The repository includes a jupyter
notebook (Setup.ipynb) that will download the dataset from figshare automatically, setting up the environment for all experiments.
The repository contains jupyter notebooks using a fast.ai20 implementation of RetinaNet. All results used to generate the plots
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Figure 4. Statistical overview of the count of mitotic figures per area of 10 high power fields (10 HPF, 2.37mm2) (bottom
right). For better visualization, the dataset was split up into two groups (according to the overall sum of mitotic figures).
Whiskers indicate absolute maximum, boxes indicate second to third quartile.The dashed red and green lines represent cut-off
values. The four images (top row and bottom left) are examples of mitotic figure distribution through the histological section
(H&E stain) using the clustering-aided (CODAEL) dataset variant. Red outlines indicate tumor region. Green dots indicate
mitotic figures. The green rectangle in each image indicates the region of maximum mitotic count in an area encompassing 10
HPF (2.37mm2).
and tables in this paper are provided alongside. Besides the network training notebooks, there is a python script to run inference
on the complete dataset, and a script to separate training from test at inference (inference on training is required to properly
determine the cutoff thresholds on the WSIs).
In the PatchClassifier subfolder, we provided the implementation of the mitotic figure / non-mitotic figure patch
classifier, also used as second stage in our experiments. Alongside with a patch extraction script (to create 128px patches
centered around the annotated cell from the WSI), there are jupyter notebooks used for the training of the second stages for
each dataset variant and an inference script that we used to yield the final results.
All database variants described in this paper have been placed in the databases folder.
Technical Validation
In order to set a baseline for our novel mammary carcinoma dataset, we performed three experiments: First, we performed a
cell classification experiment on cropped-out patches centered around the annotated pattern. Second, we conducted an object
detection experiment with the complete WSIs. Lastly, to investigate a domain transfer from canine tissue to human tissue, we
repeated this same experiment on the largest publicly available dataset from human mammary carcinoma, TUPAC1610, and
subparts thereof. We repeated all experiments five times independently to be able to report mean and standard deviation of the
metrics.
Classification of Centered Patches
For the cell classification experiment, we utilized a standard CNN classification pipeline based on a ResNet-1817 stem, pre-
trained on ImageNet24. We used the implementation available in fast.ai20 for this and employed the standard image transforms
with their default parameters. Due to the high class imbalance, we used minority class oversampling and image augmentation.
Metric MEL variant ODAEL variant CODAEL variant
Precision 0.675 ± 0.055 0.642 ± 0.040 0.679 ± 0.044
Recall 0.898 ± 0.023 0.883 ± 0.031 0.891 ± 0.028
ROC AUC 0.926 ± 0.014 0.930 ± 0.002 0.944 ± 0.007
Table 2. Cell classification experiment, based on cropped-out patches of the manually expert labeled (MEL), object
detection-augmented and expert labeled (ODAEL) and the clustering+object detection-augmented and expert labeled
(CODAEL) dataset variants. ROC AUC indicates the area under the receiver operating characteristic curve. Values represent
mean ± standard deviation of five independent training and inference runs.
Network MEL ODAEL CODAEL
Single stage (RetinaNet) 0.681 ± 0.014 0.702 ± 0.023 0.735 ± 0.013
Dual stage (RetinaNet + ResNet-18) 0.707 ± 0.013 0.785 ± 0.003 0.791 ± 0.012
Table 3. Performance assessment (F1 score) for mitotic figure detection on the test set of the three different dataset variants,
mean and standard deviation for five independent training and inference runs.
We initially trained only the randomly initialized classification head for a single epoch, while the rest of the network was
frozen. Subsequently, we unfroze the network stem and trained the network for 10 epochs using the cyclic hyper-convergence
learning-rate scheme of Smith25. During this, we already employed an early stopping paradigm to prevent overfitting. In this,
the model with the highest accuracy score was chosen. As shown in Table 2, we find a steady increase of the area under the
ROC curve (ROC AUC) with each curation step of the dataset: While the manually labeled dataset has a mean ROC AUC value
of 0.926, the clustering- and object-detection supported set already results in a mean value of 0.944.
Detection of Mitotic Figures on WSIs
For the detection of mitotic figures on whole slide images (WSIs), we employed two state-of-the-art methods: As the primary
stage, we used a customized26 RetinaNet16 approach. We used RetinaNet, since it represents a good performance to complexity
trade-off, and is available for many machine learning frameworks. As the second stage, we assessed candidates with the patch
classifier described in the previous section. We chose this dual stage setup over approaches like Faster RCNN (which integrate
two stages into a single network) because this approach offers a higher flexibility for sampling during training, and has been
shown to be successful in mitotic figure detection27. For the RetinaNet, we used only a single aspect ratio (since mitotic figures
and mitotic figure look-alikes can loosely be approximated by a quadratic bounding box), and three scales. The network was
based on a ResNet-1817 stem, pre-trained on ImageNet24. Besides standard augmentation methods, we took random crops from
the whole slide images based on a sampling scheme12 that allows it to drive network convergence by selecting patches with true
mitotic figures as well as hard negative examples. Since the WSIs already show a quite high diversity in staining, no further
color augmentation was used.
In the first step, the pre-trained network stem was frozen (learning rate = 0), to encourage a fast adaptation of the randomly
initialized object detection head. Under these conditions, the network was trained using focal loss as loss function and Adam
as optimizer for one epoch (consisting of 5,000 images, randomly selected according to the sampling scheme). Note that we
use the term epoch in this context differently: as random crops from vastly big images introduce a great deal of randomness,
it is complex to assess which parts have been used within the training already - which renders the usual definition of epoch
useless. Thus, we arbitrarily define an epoch to contain 5,000 randomly sampled images. As the next step, the network stem
was unfrozen and all weights were adapted for two cycles of 10 epochs using the super-convergence scheme25. Next, we trained
the network for another 30 epochs, and performed a selection of the model with the lowest validation loss. Towards the end of
these 30 epochs, the model would commonly be on the verge of overfitting, thus the model selection process was required to
aid generalization. The train- and validation split was performed on the upper (training) vs. lower (validation) part of the WSIs
of the training set. While this does not represent a truly statistically independent sample, it was the best compromise to ensure
training stability while still keeping the amount of WSIs that are available for training high.
In the scope of detecting mitotic figures on whole slide images, we define the detection of a true positive (TP) when the
detection and the mitotic figure annotation lie within 25 px distance of one another. If no detection (with a model score above
threshold) is present within this distance, it is counted as a false negative (FN). On the contrary, if a detection is found outside
the vicinity of an annotation, it is classified as a false positive (FP). Using the respective sum of the aforementioned counts over
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Figure 5. Patches containing mitotic figures from our canine dataset (left), the AMIDA13 cases within TUPAC16 (middle),
and the remaining cases of TUPAC16 (right). The clear difference in color representation causes a domain shift.
all slides, we define the F1 score as:
F1 =
2TP
2TP+FP+FN
(1)
In the same way, we define precision (Pr) and recall (Re) as:
Pr =
TP
TP+FP
(2)
Re =
TP
TP+FN
(3)
Test performance improved when using the dual stage algorithm compared to the single stage algorithm, and higher degrees
of algorithmic augmentation for dataset development(MEL to CODEAL dataset variant) further improved the F1 metric (see
Table 3). Standard deviations of five independent training and testing runs were small overall, proving that this dataset may be
used to train algorithms reproducibly.
Methods of label agreement
Previous datasets of mitotic figures in human mammary carcinoma used a majority vote by a third pathologist for disagreed
labels8, 10. Therefore we also used this approach to establish the ground truth for the technical validation study. In a previous
canine dataset of mitotic figures, a consensus by the same pathologists was used for ground truth12 and we used this approach
for the training of the networks used in the augmented datasets. This section aims to briefly compare these two methods. For
the CODEAL datset variant, the consensus contained 30 more mitotic figures, thus there is a negligible difference in the total
number of mitotic figures (0.22%). Training and testing with the consensus variant yielded an F1 score of 0.790, which is
comparable to the majority vote variant with the third expert (F1 of 0.791 ± 0.012).
Both methods for label agreement have potential biases in regard to label consistency (reproducible decision criteria) and
label accuracy (true label class). While the majority vote method may potentially be more representative of the general expert
opinion, introducing another expert with variable decision criteria might potentially reduce label consistency. Although future
studies need to examine the influence of these two different labeling methods, we could not find a notable difference in the total
number of labels or algorithmic performance for our datasets.
Inter-Species Transfer: Applicability on Human Breast Tissue
Human mammary carcinoma is a cancer of high prevalence worldwide. Due to the similarity of canine mammary carcinoma
and human mammary carcinoma, we aimed to investigate how applicable a system trained on the dataset proposed in this
work would be on human mammary carcinoma. Between datasets of different origins, we can expect to observe a domain
shift, effectively reducing the performance in cross-domain detection results. This domain shift might be caused by biological
differences in tumor or normal tissue between humans and dogs and variable tissue processing workflows between different
laboratories including variable WSI acquisition. Finally, we can also expect a difference in expert opinions between different
ground truth datasets which might be reflected in lower recognition performance.
To investigate this, let us have a brief look at the TUPAC1610 dataset: According to Veta et al. , the dataset was acquired
using two scanners of different types at three clinical environments. The first 23 cases, previously released as the MICCAI
AMIDA-13 dataset, were acquired using the Aperio ScanScope XT, while the remaining 84 cases were acquired using the
Leica CS400 scanner. Both scanners have very different color representation (see Figure 5), and thus cause a severe domain
shift, that shall, however, not be the scope of this work, as we only wanted to investigate the general transferability of models
training conditions test conditions F1 Score
dataset labels cases scanner single stage dual stage
only CMC TUPAC train
original labels10
73 L,A 0.528 ± 0.029 0.544 ± 0.014
only CMC TUPAC test 34 L 0.322 ± 0.032 0.268 ± 0.039
only CMC AMIDA train 12 A 0.524 ± 0.022 0.574 ± 0.019
only CMC AMIDA test 11 A 0.546 ± 0.044 0.579 ± 0.026
TO and MS on AMIDA-train AMIDA test 11 A 0.584 0.628
only CMC TUPAC-train
re-labeled28
73 L,A 0.564 ± 0.038 0.573 ± 0.019
only CMC TUPAC-test 34 L 0.298 ± 0.044 0.218 ± 0.036
only CMC AMIDA-train 12 A 0.592 ± 0.043 0.645 ± 0.016
only CMC AMIDA-test 11 A 0.594 ± 0.047 0.635 ± 0.028
TO and MS on AMIDA-train AMIDA-test 11 A 0.628 0.696
TL on AMIDA-train AMIDA-test 11 A 0.720 ± 0.022 0.733 ± 0.007
Table 4. Mitotic figure detection performance (F1 Score), when trained on the final canine mammary carcinoma (CMC)
dataset and tested on the TUPAC16 dataset and its subsets (including AMIDA-13), without any domain adaptation and with
only threshold optimization (TO) and model selection (MS), or with transfer learning (TL) performed on the target domain.
Values given are mean and standard deviations of five independent training and inference runs. The histological images (cases)
were obtained with Aperio ScanScope XT (A) or Leica SCN400 (L) scanner, both with a resolution of 0.25 microns per pixel
(400X magnification)
trained on canine tissue. The images used for the canine specimens (scanned with Aperio ScanScope CS2) seem to have similar
color representation as compared to human images scanned with the Aperio ScanScope XT.
To undertake the question of reduced generalization caused by different opinions of the annotators, we re-labeled the
TUPAC16 set with very similar methods, using experts from the present study28.
Looking at Table 4, we can see that the domain transfer task yields mean F1 scores of 0.544 on the training set of TUPAC16.
At first glance, this seems like a significant reduction in performance, compared to what the system trained on the same dataset
achieved on the test set presented in this work.
As shown in Table 4, the performance is already better if we limit the task to the AMIDA13 dataset, or the test set thereof,
which can likely be explained by the similar color representation between the human and canine images. In contrast, testing on
the TUPAC-test set, which comprises exclusively of images from the Leica SCN400 scanner, has a lower F1 score. As the
second stage of our algorithm is specifically trained to distinguish difficult patterns, it is likely to show a stronger dependency
on the domain. Thus a change in color representation might lead to inferior performance, compared to the single stage approach
as shown in the present study.
Performance was further improved when testing on the re-labeled ground truth, which likely has higher annotation
consistency to the canine dataset. This underscores the importance of consistent labeling methods when algorithms are to be
tested on independent datasets. We further performed model selection (MS) and optimization of the threshold (TO) on the
AMIDA training set as a step towards further domain adaptation, resulting in a higher F1 score of 0.696.
A common approach when a big and more representative dataset and a smaller target-domain dataset are available is
transfer learning. For this, a model that was trained on the original, large dataset is fine-tuned on the smaller dataset. In order
to estimate the remaining domain shift of the Aperio ScanScope-scanned slides of the TUPAC dataset (i.e., the AMIDA-13
dataset), we thus additionally performed model fine-tuning using the training part of the AMIDA-13 dataset, and evaluated it on
the respective test set. Our results in Table 4 indicate that there is a residual domain shift, likely caused by variability in tissue
processing or quality, or by the fact that only hot spot regions were annotated for the AMIDA-13 dataset, and not the whole
WSI.
In summary, we can observe a strong domain shift that can be largely attributed to the scanner that was used for the
digitization of images, and a much lesser domain shift caused by a combination of processing differences (such as staining,
section thickness, etc.) or species. Additionally, we found a decrease in performance that can be attributed to label inconsistency,
either caused by differences in expert opinion or by using a different labeling workflow. Results of this domain transfer
experiment suggest that this dataset may be valuable for training or testing mitotic figure algorithms for human breast cancer as
we provide annotations for entire WSIs.
Usage Notes
Annotations are provided in the SlideRunner database format15, which can be also used to view the WSIs with all annotations,
but also in the popular MS COCO format. The latter, however, only contains the final annotation class and not the annotation
history (i.e., the multiple labels given by multiple experts).
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